Identification and validation of potential diagnostic signature and immune cell infiltration for HIRI based on

Fang Xiao1,2,3, Guozhen Huang1,2,3, Guandou Yuan1,2,3

  • 1Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

PubMed

Insights

Cuproptosis-related genes (CRGs) are linked to hepatic ischemia and reperfusion injury (HIRI). Three hub CRGs (NLRP3, ATP7B, NFE2L2) show diagnostic potential for HIRI, offering new therapeutic targets.

Area of Science:

  • Biochemistry
  • Genetics
  • Immunology

Background:

  • Cuproptosis, a regulated cell death pathway, is increasingly implicated in disease pathogenesis.
  • Hepatic ischemia and reperfusion injury (HIRI) is a critical clinical challenge with significant morbidity.
  • Understanding the molecular underpinnings of HIRI is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of cuproptosis-related genes (CRGs) in the development of HIRI.
  • To identify potential diagnostic biomarkers and therapeutic targets for HIRI based on CRGs.

Main Methods:

  • Bioinformatic analysis of HIRI datasets from Gene Expression Omnibus (GEO).
  • Differential gene expression analysis of CRGs, correlation analysis, and pathway enrichment.
  • Machine learning models to identify hub CRGs, followed by validation using qPCR and Western blotting.

Main Results:

  • Three hub CRGs (NLRP3, ATP7B, NFE2L2) were identified and demonstrated high diagnostic accuracy for HIRI (AUC 0.832–0.904).
  • Enrichment analyses revealed CRG involvement in HIRI-related pathways.
  • Elevated expression of hub CRGs was observed in immune cells within HIRI samples, suggesting immune system involvement.

Conclusions:

  • CRGs, particularly NLRP3, ATP7B, and NFE2L2, represent promising diagnostic biomarkers for HIRI.
  • These findings provide novel insights into HIRI mechanisms and potential therapeutic strategies targeting cuproptosis.
Abstract

Related Concept Videos